PDE9A and neoplasm: Conversely, AL031985.3, FARSA-AS1, LINC01762, PDE9A-AS1, AC104964.3, and AC092375.2 showed lower expression levels in tumor tissues than the corresponding matched-peritumoral samples (Figure 9B).